KINISOQUIN FX
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 May 2024)
What this means for you
This application is over — abandoned 27 May 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88836229
- Mark type
- Stylized text
- Filed
- 16 Mar 2020
- Published for opposition
- 23 Feb 2021
- Abandoned
- 27 May 2024
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19
Owner
- Quercis Pharma AG, Zug, CH
- Quercis Pharma AG, Zug, CH
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 May 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2023 — SOU EXTENSION 5 GRANTED
- 20 Oct 2023 — SOU EXTENSION 5 FILED
- 20 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2023 — SOU EXTENSION 4 GRANTED
- 20 Apr 2023 — SOU EXTENSION 4 FILED
- 20 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2022 — SOU EXTENSION 3 GRANTED
- 19 Oct 2022 — SOU EXTENSION 3 FILED
- 19 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 17 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED